Oncology & Cancer

Programming the immune system to supercharge cancer cell therapies

The first FDA-approved gene therapies are living drugs: immune cells taken from cancer patients engineered to target tumor cells. However, for many patients, these advanced therapies do not result in a long-lasting remission. ...

Medical research

Scientists 'supercharge' cancer-fighting T cells

Yale scientists have identified a way to "supercharge" tumor-attacking T cells, a finding that may not only improve the effectiveness of a promising type of cell-based cancer immunotherapy but also expand the number of cancers ...

Health informatics

US traffic deaths rise to highest level since 2007

Even though Americans drove less in the early days of the COVID-19 pandemic, close to 39,000 lives were lost on U.S. roadways in 2020—the highest death toll since 2007, the U.S. National Highway Traffic Safety Administration ...

Oncology & Cancer

New precision technology for human glioma immunotherapy

In recent years, great advances have been made in the development of new successful immunotherapies to treat cancer. CAR T-cell therapy and antibody treatments are two types of targeted immunotherapies that have revolutionized ...

page 24 from 40